US Patent 11034746 Double-acylated GLP-1 derivatives
Patent 11034746 was granted and assigned to Novo Nordisk on June, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11034746 Double-acylated GLP-1 derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.